TW202417500A - 與 cd3 及 cd19 結合之抗體 - Google Patents

與 cd3 及 cd19 結合之抗體 Download PDF

Info

Publication number
TW202417500A
TW202417500A TW112126378A TW112126378A TW202417500A TW 202417500 A TW202417500 A TW 202417500A TW 112126378 A TW112126378 A TW 112126378A TW 112126378 A TW112126378 A TW 112126378A TW 202417500 A TW202417500 A TW 202417500A
Authority
TW
Taiwan
Prior art keywords
antibodies
antibodies binding
methods
present
relates
Prior art date
Application number
TW112126378A
Other languages
English (en)
Inventor
葛倫雪伯 安 富雷摩捨
尼可利尼 瑪麗亞 維樂瑞雅 岡薩雷斯
勞福 荷斯
亞歷山大 諾普
艾克哈得 摩斯納
沃爾夫剛 瑞屈特
哈林娜 崔村諾史加
帕洛 尤瑪那
克里斯俊 克萊
櫻加 華德豪爾
Original Assignee
瑞士商赫孚孟拉羅股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑞士商赫孚孟拉羅股份公司 filed Critical 瑞士商赫孚孟拉羅股份公司
Publication of TW202417500A publication Critical patent/TW202417500A/zh

Links

Abstract

本發明一般涉及與 CD3 及 CD19 結合之抗體，其例如用於活化 T 細胞。另外，本發明涉及編碼此等抗體之多核苷酸，以及包含此等多核苷酸之載體及宿主細胞。本發明進一步涉及產生該等抗體之方法，以及使用該等抗體治療疾病之方法。
TW112126378A 2020-06-19 2021-06-17 與 cd3 及 cd19 結合之抗體 TW202417500A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20181056.1 2020-06-19

Publications (1)

Publication Number Publication Date
TW202417500A true TW202417500A (zh) 2024-05-01

Family

ID=

Similar Documents

Publication Publication Date Title
WO2021018859A3 (en) Antibodies binding to gprc5d
PH12020551211A1 (en) Antibodies binding to gprc5d
MY194642A (en) Antibodies binding to cd3
MX2022016069A (es) Anticuerpos que se unen a cd3 y cd19.
MX2022001830A (es) Anticuerpos terapeuticos y sus usos.
JOP20200313A1 (ar) أجسام مضادة dll3-cd3 ثنائية الخاصية
MX2018013548A (es) Proteinas de union biespecificas y usos de las mismas.
JOP20190017A1 (ar) أجسام مضادة ترتبط مع مستقبل cgrp بشري
EP3812398A3 (en) Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123
CR20220628A (es) Anticuerpos que se unen a cd3
WO2019224717A3 (en) Anti-cd3 antibodies and uses thereof
CR20220629A (es) Moléculas de unión al dominio fc de activación inmunitaria
WO2008119566A3 (en) Cross-species-specific bispecific binders
MX2022007635A (es) Anticuerpos que se unen a hla-a2/mage-a4.
PH12019502274A1 (en) Antibodies binding to steap-1
CR20220639A (es) Anticuerpos que se unen a cd3 y folr1
WO2019122052A3 (en) Antibodies binding to hla-a2/wt1
CR20220025A (es) Proteínas que comprenden dominios de unión al antígeno de la peptidasa 2 relacionada con la calicreína y sus usos
WO2021127200A8 (en) Ilt3-binding agents and methods of use thereof
WO2021262597A3 (en) Lair-1-binding agents and methods of use thereof
WO2016164657A3 (en) Antibody therapeutics that bind cd123
WO2022175255A3 (en) Trispecific antibody targeting bcma, gprc5d, and cd3
WO2020172621A8 (en) Cd33 antibodies and methods of using the same to treat cancer
MX2021009275A (es) Moleculas de union especificas.
MX2020001287A (es) Receptor de linfocitos t (tcrs) especificos de braf y usos de los mismos.